Research Article

Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study

Table 5

Treatment characteristics of the study sample.

VariableESA + IV IronESA alone Total

Treatment characteristics

ESA type*
 Epoetin3428 (51.3)44106 (57.8)47534 (57.3)
 Darbepoetin2082 (31.2)32163 (42.2)34245 (41.3)
 Unknown1168 (17.5)0 (0)1168 (1.4)

IV iron type
 Iron sucrose5678 (85)NANA
 Iron dextran1000 (15)

*Differences between the study groups were statistically significance at .